Literature DB >> 11017111

LMP2 expression and proteasome activity in NOD mice.

B M Kessler, A M Lennon-Duménil, M L Shinohara, M A Lipes, H L Ploegh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11017111     DOI： 10.1038/80346

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

Review 1.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

2.  Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.

Authors:  Eun Ryoung Jang; Na-Ra Lee; Songhee Han; Ying Wu; Lalit Kumar Sharma; Kimberly Cornish Carmony; James Marks; Do-Min Lee; Jung-Ok Ban; Marie Wehenkel; Jin Tae Hong; Kyung Bo Kim; Wooin Lee
Journal:  Mol Biosyst       Date:  2012-06-22

3.  Immunoproteasome in the blood plasma of children with acute appendicitis, and its correlation with proteasome and UCHL1 measured by SPR imaging biosensors.

Authors:  E Matuszczak; A Sankiewicz; W Debek; E Gorodkiewicz; R Milewski; A Hermanowicz
Journal:  Clin Exp Immunol       Date:  2017-10-16       Impact factor: 4.330

4.  Co-inhibition of immunoproteasome subunits LMP2 and LMP7 is required to block autoimmunity.

Authors:  Michael Basler; Michelle M Lindstrom; Jacob J LaStant; J Michael Bradshaw; Timothy D Owens; Christian Schmidt; Elmer Maurits; Christopher Tsu; Herman S Overkleeft; Christopher J Kirk; Claire L Langrish; Marcus Groettrup
Journal:  EMBO Rep       Date:  2018-10-02       Impact factor: 8.807

Review 5.  Inhibitors of the immunoproteasome: current status and future directions.

Authors:  Zachary Miller; Lin Ao; Kyung Bo Kim; Wooin Lee
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice.

Authors:  M Wehenkel; J-O Ban; Y-K Ho; K C Carmony; J T Hong; K B Kim
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

Review 7.  Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.

Authors:  Nathalie Vigneron; Benoît J Van den Eynde
Journal:  Biomolecules       Date:  2014-11-18

8.  Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice.

Authors:  Hiroaki J Kimura; Cindy Y Chen; Shey-Cherng Tzou; Roberto Rocchi; Melissa A Landek-Salgado; Koichi Suzuki; Miho Kimura; Noel R Rose; Patrizio Caturegli
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

9.  Immunoproteasome deficiency modifies the alternative pathway of NFκB signaling.

Authors:  Marcela Maldonado; Rebecca J Kapphahn; Marcia R Terluk; Neal D Heuss; Ching Yuan; Dale S Gregerson; Deborah A Ferrington
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

10.  Slc11a1 enhances the autoimmune diabetogenic T-cell response by altering processing and presentation of pancreatic islet antigens.

Authors:  Yang D Dai; Idania G Marrero; Philippe Gros; Habib Zaghouani; Linda S Wicker; Eli E Sercarz
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.